The Singapore Impaired Glucose Tolerance Follow-Up Study: Does the ticking clock go backward as well as forward?

Diabetes Care

Volumn 26, Issue 11, 2003, Pages 3024-3030

  Wong, Moh Sim ^a,b   Gu, Ken ^c   Heng, Derrick ^c   Chew, Suok Kai ^d   Chew, Loy Soong ^b   Tai, E Shyong ^e  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b ALEXANDRA HOSPITAL   (Singapore)

^c Clinical Trials and Epidemiology Research Unit   (Singapore)

^d MINISTRY OF HEALTH   (Singapore)

^e SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID;

ADULT; AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; FOLLOW UP; GENDER; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PROPHYLAXIS; SINGAPORE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; SINGAPORE;

EID: 0242269010     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.11.3024     Document Type: Article

References (37)

1. Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18:258-268, 1995
2. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100:1134-1146, 1999
3. The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
4. Cohen O, Norymberg K, Neumann E, Dekel H: Complication-free duration and the risk of development of retinopathy in elderly diabetic patients. Arch Intern Med 158:641-644, 1998
5. Marshall G, Garg SK, Jackson WE, Holmes DL, Chase HP: Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. Ophthalmology 100:1133-1139, 1993
6. Nathan DM, Singer DE, Godine JE, Harrington CH, Perlmuter LC: Retinopathy in older type II diabetics: association with glucose control. Diabetes 35:797-801, 1986
7. Nathan DM, Singer DE, Godine JE, Perlmuter LC: Non-insulin-dependent diabetes in older patients: complications and risk factors. Am J Med 81:837-842, 1986
8. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263:2893-2898, 1990
9. McPhillips JB, Barrett-Connor E, Wingard DL: Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol 131:443-453, 1990
10. Klein BE, Klein R, Lee KE: Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dato dam. Diabetes Care 25:1790-1794, 2002
11. Perry IJ, Wannamethee SG, Walker MK, Thomson AG, Whincup PH, Shaper AG: Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ 310:560-564, 1995
12. Njolstad I, Arnesen E, Lund-Larsen PG: Sex differences in risk factors for clinical diabetes mellitus in a general population: a 12-year follow-up of the Finnmark Study. Am J Epidemiol 147:49-58, 1998
13. Mykkanen L, Kuusisto J, Pyorala K, Laakso M: Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36:553-559, 1993
14. Chou P, Li CL, Wu GS, Tsai ST: Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen: exploring the natural history of type 2 diabetes. Diabetes Care 21:1183-1187, 1998
15. Jacobsen BK, Bonaa KH, Njolstad I: Cardiovascular risk factors, change in risk factors over 7 years, and the risk of clinical diabetes mellitus type 2: the Tromso study. J Clin Epidemiol 55:647-653, 2002
16. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
17. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
18. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544, 1997
19. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072-2077, 2002
20. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319:1500-1506, 1988
21. Qiao Q, Keinanen-Kiukaanniemi S, Rajala U, Uusimaki A, Kivela SL: Risk for diabetes and persistent impaired glucose tolerance among middle-aged Finns. Diabetes Res Clin Pract 33:191-198, 1996
22. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Bennett PH: Transient impaired glucose tolerance in Pima Indians: is it important? BMJ 297:1438-1441, 1988
23. Motala AA, Omar MA, Gouws E: Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM. Diabetes Care 20:1101-1107, 1997
24. Bourn DM, Williams SM, Mann JI: Distinguishing between persistent and transient impaired glucose tolerance using a prediction model. Diabet Med 9:744-748, 1992
25. Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ: Cardiovascular risk factors prior to the development of non-insulin-dependent diabetes mellitus in persons with impaired glucose tolerance: the Hoorn Study. J Clin Epidemiol 50:1003-1009, 1997
26. Tan CE, Emmanuel SC, Tan BY, Jacob E: Prevalence of diabetes and ethnic differences in cardiovascular risk factors: the 1992 Singapore National Health Survey. Diabetes Care 22:241-247, 1999
27. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
29. Lim SC, Tai ES, Tan BY, Chew SK, Tan CE: Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report. Diabetes Care 23:278-282, 2000
30. Laakso M, Barrett-Connor E: Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis. Arteriosclerosis 9:665-672, 1989
31. Burchfiel CM, Hamman RF, Marshall JA, Baxter J, Kahn LB, Amirani JJ: Cardiovascular risk factors and impaired glucose tolerance: the San Luis Valley Diabetes Study. Am J Epidemiol 131:57-70, 1990
32. Capaldo B, Tutino L, Patti L, Vaccaro O, Rivellese A, Riccardi G: Lipoprotein composition in individuals with impaired glucose tolerance. Diabetes Care 6:575-578, 1983
33. Larsson H, Lindgarde F, Berglund G, Ahren B: Prediction of diabetes using ADA or WHO criteria in post-menopausal women: a 10-year follow-up study. Diabetologia 43:1224-1228, 2000
34. Vaccaro O, Ruffa G, Imperatore G, Iovino V, Rivellese AA, Riccardi G: Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care 22:1490-1493, 1999
35. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H, Hemraj F, Fareed D, Tuomilehto J, Alberti KG: Impaired fasting glucose or impaired glucose tolerance: what best predicts future diabetes in Mauritius? Diabetes Care 22:399-402, 1999
36. Pettit DJ, Narayan KM, Hanson RL, Knowler WC: Incidence of diabetes mellitus in women following impaired glucose tolerance in pregnancy is lower than following impaired glucose tolerance in the non-pregnant state. Diabetologia 39:1334-1337, 1996
37. King H, Zimmet P, Raper LR, Balkau B: The natural history of impaired glucose tolerance in the Micronesian population of Nauru: a six-year follow-up study. Diabetologia 26:39-43, 1984